Skip to content

Clinical trials

Fatty Liver trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Country / region: China Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20082
20101
20111
20121
20131
20141
20154
20172
20182
20191
20201
20214
20222
20232
20247
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14
Completed11
Recruiting11
Enrolling by invitation2
Active, not recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Friendship Hospital3
Beijing Jishuitan Hospital2
Fatty Liver and Alcoholic Liver Disease Study Group, China2
Sanofi2
Zhejiang Chinese Medical University2
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC1
Beijing Municipal Administration of Hospitals1
Chongqing Medical University1
Dong Peng1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver43
Non-alcoholic Fatty Liver Disease14
Liver Cirrhosis9
Diabetes Mellitus4
Fibrosis4
Metabolic Syndrome4
Obesity4
Hepatitis B, Chronic3
Binge Drinking2
Diabetes Mellitus, Type 22

Trials

Showing 51 to 43 of 43. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.